Bio-Rad Infringed Three 10X Patents, Federal Circuit Affirms

Bio-Rad Laboratories Inc. can’t shake a trade agency ruling that it infringed three gene-sequencing patents owned by 10X Genomics Inc., the Federal Circuit ruled.

Bio-Rad argued it couldn’t infringe the patents because its former researchers, who left to form 10X, should be listed as co-inventors of the technology. The U.S. Court of Appeals for the Federal Circuit rejected that argument in a precedential opinion.

A contract that assigns all inventions made during employment with a company doesn’t reach inventions conceived after the term of the agreement, even if those inventions were based on work done while the employee was ...